Lindsay E Cassey, DO
Osteopathic Manipulative Medicine · Folsom
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 5
Offices
5 locations · Sutter Valley Medical Foundation · Sutter Bay Medical Foundation
Hospitals listed: Sutter Medical Center, Sacramento · Sutter Roseville Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Cassey’s office to ask if they take your plan before you enroll.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Sutter Medical Center, SacramentoSacramento, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 79% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 13.9 (12 to 15.9) · 992 cases, Jan 2024 – Dec 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.066, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.335, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.215, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.46, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.253, Oct 2024 – Sep 2025
- Sutter Roseville Medical CenterRoseville, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Pressure ulcer rate: 0.08 (0 to 0.56) · 12,400 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.069, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.262, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.128, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.357, Oct 2024 – Sep 2025
See every measure and the patient survey for Sutter Medical Center, Sacramento
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.9 (12 to 15.9) · 992 cases | Worse | Jan 2024 – Dec 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.066 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.335 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.215 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.46 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.253 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.12 (0.29 to 1.94) · 2,408 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.99 (0.78 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.68 (126.66 to 206.71) · 180 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 292 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 359 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.8 · 543 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.9 · 425 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 441 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 5,216 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.11 (0 to 0.29) · 9,948 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.1 to 0.45) · 10,968 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.04 (1.53 to 4.56) · 3,983 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.33 (0.2 to 2.46) · 2,033 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.78 (1.69 to 3.87) · 3,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.79 (6.29 to 13.29) · 2,100 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.62 (4.04 to 9.2) · 2,018 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.63 (0.29 to 2.98) · 867 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.54 (0.07 to 1.01) · 8,613 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 294 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 598 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 924 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 8.5 · 488 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -18.3 · 638 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.4 · 443 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.7 · 600 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (3.9 to 6.1) · 992 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 298 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9 · 249 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 250 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.3 (8.7 to 14.6) · 1,326 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 934 cases | No different | Jan 2024 – Dec 2024 |
What patients said (700 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Sutter Roseville Medical Center
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 5 better, 1 the same, 1 worse of 7 measures. Readmissions: 2 better, 7 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Pressure ulcer rateComplications and deaths | 0.08 (0 to 0.56) · 12,400 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.069 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.262 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.128 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.357 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.33 (0.49 to 2.17) · 2,916 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.9 (0.63 to 1.17) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 147.2 (107.33 to 187.07) · 191 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 250 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.7 · 484 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 839 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.3 · 1,027 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10 · 656 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 6,822 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.25 (0.08 to 0.42) · 14,300 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.06 to 0.41) · 14,490 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.43 (2.77 to 6.08) · 3,117 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.38 (0 to 2.95) · 938 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.06 (0.76 to 3.36) · 2,944 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.03 (2.8 to 15.25) · 840 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.43 (3.11 to 9.75) · 899 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.34 to 3.11) · 819 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.4 · 35 cases | None | Apr 2023 – Mar 2025 |
| SSI - Colon SurgeryInfections | 0.41 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 527 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 1,094 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -16.6 · 443 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -11 · 961 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -8 · 1,064 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 1,293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.5 to 8.7) · 35 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (6.9 to 14.9) · 35 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.5 · 310 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.8 to 17.9) · 116 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 1,600 cases | No different | Jan 2024 – Dec 2024 |
What patients said (537 patients answered, 24% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$33,012
Medicare paid this office $33,012 for 280 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 187 | $14,726 | $69 |
| Short return visit (20+ min) | 102 | $6,091 | $50 |
| Sarscov2 vac 50 mcg/0.5ml im | 12 | $1,716 | $143 |
| Telephone medical discussion with physician, 11-20 minutes | 19 | $1,271 | $55 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 12 | $703 | $59 |
See all 9 services
| Return visit (30+ min) | 187 | $14,726 | $69 |
| Short return visit (20+ min) | 102 | $6,091 | $50 |
| Sarscov2 vac 50 mcg/0.5ml im | 12 | $1,716 | $143 |
| Telephone medical discussion with physician, 11-20 minutes | 19 | $1,271 | $55 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 12 | $703 | $59 |
| Admn sarscov2 vacc 1 dose | 12 | $546 | $46 |
| Administration of influenza virus vaccine | 14 | $478 | $34 |
| Injection of drug or substance under skin or into muscle | 11 | $208 | $12 |
| Automated urinalysis test | 19 | $42 | $2 |
Who their Medicare patients are
280 Original Medicare patients in 2024. Average age 75 · Under 65 10% · 85 and older 13% · Women 73% · Also on Medicaid 13% · Health risk score 1.24. Above the middle of the specialty; the typical osteopathic manipulative medicine clinician is at 1.08.
Conditions among them: High blood pressure 73% · Depression 28% · Coronary heart disease 24% · Diabetes 23% · Chronic kidney disease 22% · Atrial fibrillation 18% · Heart failure 17% · Cancer 16% · COPD 15% · Stroke 9% · Dementia 6%.
The office billed $179,110, Medicare allowed $52,498 and paid $33,012; for 637 services of 48 kinds; $5,407 of it was for drugs given in the office and $27,605 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 280 | 637 | 75 | 1.24 | $179,110 | $33,012 |
| 2023 | 323 | 896 | 74 | 1.12 | $304,206 | $53,204 |
| 2022 | 199 | 665 | 70 | 1.15 | $169,850 | $35,091 |
| 2021 | 13 | 32 | 60 | 1.30 | $1,309 | $167 |
| 2019 | 36 | 121 | 62 | 1.71 | $5,758 | $1,102 |
| 2018 | 31 | 40 | 63 | 1.25 | $1,079 | $326 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Return visit (30+ min) | 195 | $16,383 | $58 |
| Short return visit (20+ min) | 115 | $7,757 | $51 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 21 | $5,941 | $283 |
| Influenza vaccine split virus, preservative free | 60 | $4,316 | $72 |
| Sarscov2 vac 50 mcg/0.5ml im | 28 | $4,004 | $143 |
| Administration of influenza virus vaccine | 66 | $2,125 | $32 |
| Telephone medical discussion with physician, 11-20 minutes | 26 | $2,013 | $72 |
| New patient visit (45+ min) | 20 | $1,983 | $99 |
| Short return visit | 27 | $1,230 | $42 |
| Admn sarscov2 vacc 1 dose | 28 | $1,202 | $43 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 15 | $912 | $61 |
| Administration of pneumococcal vaccine | 24 | $773 | $32 |
| Removal of impacted ear wax by washing | 12 | $135 | $11 |
2022: 12 services
| Return visit (30+ min) | 79 | $8,679 | $80 |
| Short return visit (20+ min) | 95 | $6,954 | $58 |
| New patient visit (45+ min) | 28 | $3,299 | $118 |
| Influenza vaccine split virus, preservative free | 22 | $1,508 | $69 |
| Telephone medical discussion with physician, 11-20 minutes | 13 | $1,070 | $76 |
| Administration of influenza virus vaccine | 30 | $934 | $31 |
| New patient visit (30+ min) | 12 | $924 | $77 |
| Short return visit | 20 | $901 | $45 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 13 | $591 | $45 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 13 | $528 | $41 |
| Administration of pneumococcal vaccine | 12 | $375 | $31 |
| Automated urinalysis test | 12 | $29 | $2 |
2019: 1 service
| Hemoglobin a1c level | 24 | $317 | $11 |
2018: 1 service
| Hemoglobin a1c level | 15 | $172 | $11 |
Medicaid work
$405,304 in 2022
Medicaid paid $405,304 for 6,458 billed services this clinician did in 2022, up to 119 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 790 | $72,324 |
| New patient visit (30+ min) | 248 | $61,295 |
| Etonogestrel (contraceptive) implant system, including implant and supplies | 53 | $51,938 |
| Return visit (30+ min) | 412 | $47,603 |
| Short return visit | 429 | $28,488 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; HIV-1 antigen(s), with HIV-1 and HIV-2 antibodies | 1,064 | $25,186 |
| Contraceptive pills for bc | 222 | $24,144 |
| Unclassified drugs | 464 | $23,198 |
| Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs | 31 | $17,288 |
| Clinic visit/encounter, all-inclusive | 65 | $14,911 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 101 | $11,971 |
| New patient visit (45+ min) | 14 | $3,299 |
| 2022 | 6,458 | 29 | 119 | $405,304 |
| 2021 | 13,269 | 32 | 159 | $785,470 |
| 2020 | 21,713 | 35 | 235 | $1,328,847 |
| 2019 | 22,253 | 38 | 212 | $1,409,908 |
| 2018 | 22,922 | 34 | 240 | $1,603,306 |
See the largest Medicaid services in earlier years
2021
| Clinic visit/encounter, all-inclusive | 1,261 | $292,162 |
| New patient visit (30+ min) | 460 | $97,993 |
| Short return visit (20+ min) | 1,994 | $97,268 |
| Return visit (30+ min) | 1,287 | $64,485 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; HIV-1 antigen(s), with HIV-1 and HIV-2 antibodies | 2,219 | $51,196 |
| Short return visit | 604 | $41,088 |
| Contraceptive pills for bc | 356 | $38,513 |
| Unclassified drugs | 717 | $29,583 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 179 | $23,294 |
| Etonogestrel (contraceptive) implant system, including implant and supplies | 13 | $12,351 |
| Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs | 21 | $11,711 |
| URINE PREGNANCY TEST | 1,241 | $3,849 |
2020
| Clinic visit/encounter, all-inclusive | 1,480 | $342,494 |
| Return visit (30+ min) | 1,811 | $171,212 |
| Short return visit (20+ min) | 2,534 | $143,368 |
| Contraceptive pills for bc | 851 | $104,123 |
| Unclassified drugs | 1,505 | $85,277 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; HIV-1 antigen(s), with HIV-1 and HIV-2 antibodies | 3,460 | $83,481 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 443 | $75,572 |
| Etonogestrel (contraceptive) implant system, including implant and supplies | 65 | $67,359 |
| Short return visit | 994 | $60,693 |
| INDUCED ABORTION DILATION AND CURETTAGE | 48 | $26,062 |
| Contraceptive supply, hormone containing vaginal ring, each | 42 | $25,213 |
| New patient visit (30+ min) | 225 | $24,186 |
2019
| Clinic visit/encounter, all-inclusive | 1,574 | $383,083 |
| Return visit (30+ min) | 2,024 | $197,978 |
| Short return visit (20+ min) | 2,224 | $165,832 |
| Contraceptive pills for bc | 1,116 | $132,261 |
| Short return visit | 1,355 | $113,702 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 481 | $89,492 |
| Etonogestrel (contraceptive) implant system, including implant and supplies | 82 | $68,161 |
| Unclassified drugs | 1,270 | $60,203 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; HIV-1 antigen(s), with HIV-1 and HIV-2 antibodies | 1,849 | $45,919 |
| OFFICE/OUTPATIENT VISIT NEW | 360 | $35,336 |
| OFF/OP EST MAY X REQ PHY/QHP | 584 | $32,942 |
| Insertion, drug-delivery implant (ie, bioresorbable, biodegradable, non-biodegradable) | 82 | $17,662 |
2018
| Clinic visit/encounter, all-inclusive | 2,131 | $343,501 |
| Return visit (30+ min) | 1,591 | $281,727 |
| Short return visit (20+ min) | 2,337 | $185,493 |
| Contraceptive pills for bc | 1,262 | $153,993 |
| Short return visit | 1,158 | $109,278 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 555 | $102,605 |
| Etonogestrel (contraceptive) implant system, including implant and supplies | 120 | $100,812 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; HIV-1 antigen(s), with HIV-1 and HIV-2 antibodies | 2,504 | $64,376 |
| Unclassified drugs | 1,434 | $60,112 |
| OFFICE/OUTPATIENT VISIT NEW | 349 | $38,246 |
| OFF/OP EST MAY X REQ PHY/QHP | 548 | $32,234 |
| New patient visit (30+ min) | 92 | $29,890 |
Drugs they prescribed that Part D paid
$266,954
Pharmacies billed $266,954 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (79 of 3,055) in 2024. Above the middle of the specialty; the typical osteopathic manipulative medicine clinician is at 1%. Long-acting opioids: 39% of their opioid prescriptions.
2,675 generic and 358 brand-name prescriptions · $266,954 in drug cost · 61 antibiotic prescriptions to 52 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 59 | $64,195 | $1,088 |
| Jardiance | 26 | $30,512 | $1,174 |
| Eliquis | 28 | $25,174 | $899 |
| Januvia | 20 | $9,842 | $492 |
| Spiriva Respimat | 12 | $8,885 | $740 |
See all 68 drugs
| Ozempic | 59 | $64,195 | $1,088 |
| Jardiance | 26 | $30,512 | $1,174 |
| Eliquis | 28 | $25,174 | $899 |
| Januvia | 20 | $9,842 | $492 |
| Spiriva Respimat | 12 | $8,885 | $740 |
| Buprenorphine | 21 | $4,223 | $201 |
| Atorvastatin | 205 | $2,424 | $12 |
| Gabapentin | 131 | $2,311 | $18 |
| Lidocaine | 19 | $2,170 | $114 |
| Levothyroxine | 177 | $2,154 | $12 |
| Albuterol Sulfate Hfa | 60 | $1,385 | $23 |
| Estradiol | 13 | $1,368 | $105 |
| Hydrocodone-Acetaminophen | 42 | $1,043 | $25 |
| Rosuvastatin | 57 | $997 | $17 |
| Buprenorphine-Naloxone | 16 | $993 | $62 |
| Duloxetine | 34 | $872 | $26 |
| Nano 2nd Gen Pen Needle | 11 | $851 | $77 |
| Losartan | 99 | $819 | $8 |
| Lisinopril | 94 | $797 | $8 |
| Mirtazapine | 26 | $780 | $30 |
| Amlodipine Besylate | 82 | $764 | $9 |
| Baclofen | 34 | $750 | $22 |
| Fluticasone Propionate | 30 | $661 | $22 |
| Omeprazole | 38 | $538 | $14 |
| Donepezil | 11 | $523 | $48 |
| Potassium Chloride | 24 | $515 | $21 |
| Simvastatin | 69 | $474 | $7 |
| Montelukast | 23 | $467 | $20 |
| Ezetimibe | 20 | $455 | $23 |
| Trazodone | 31 | $452 | $15 |
| Fenofibrate | 13 | $442 | $34 |
| Tamsulosin | 11 | $440 | $40 |
| Azelastine | 14 | $432 | $31 |
| Escitalopram | 24 | $416 | $17 |
| Pantoprazole | 56 | $404 | $7 |
| Pravastatin | 32 | $397 | $12 |
| Metformin | 66 | $394 | $6 |
| Losartan-Hydrochlorothiazide | 16 | $376 | $23 |
| Sertraline | 65 | $367 | $6 |
| Metformin Hcl Er | 19 | $340 | $18 |
| Atenolol | 29 | $332 | $11 |
| Desvenlafaxine Succinate Er | 12 | $331 | $28 |
| Naproxen | 26 | $327 | $13 |
| Venlafaxine Hcl Er | 13 | $281 | $22 |
| Hydrochlorothiazide | 44 | $270 | $6 |
| Diclofenac | 15 | $255 | $17 |
| Triamterene-Hydrochlorothiazid | 19 | $251 | $13 |
| Hydroxyzine | 21 | $241 | $11 |
| Metoprolol | 21 | $235 | $11 |
| Famotidine | 33 | $234 | $7 |
| Ibuprofen | 32 | $217 | $7 |
| Cyclobenzaprine | 31 | $208 | $7 |
| Sumatriptan | 11 | $206 | $19 |
| Bupropion | 12 | $201 | $17 |
| Alendronate | 37 | $183 | $5 |
| Furosemide | 58 | $177 | $3 |
| Amitriptyline | 17 | $170 | $10 |
| Mupirocin | 20 | $168 | $8 |
| Ropinirole | 13 | $168 | $13 |
| Pregabalin | 17 | $156 | $9 |
| Benazepril | 12 | $137 | $11 |
| Metoprolol | 47 | $100 | $2 |
| Glimepiride | 11 | $99 | $9 |
| Nitrofurantoin Mono-Macro | 11 | $96 | $9 |
| Amoxicillin-Clavulanate Potass | 11 | $84 | $8 |
| Spironolactone | 12 | $73 | $6 |
| Cephalexin | 16 | $56 | $4 |
| Meloxicam | 12 | $30 | $3 |
Year by year
| 2024 | 3,055 | 358 | 3% (79) | 12% | $266,954 |
| 2023 | 1,731 | 298 | 5% (84) | 12% | $170,098 |
| 2022 | 930 | 212 | 2% (16) | 13% | $86,765 |
| 2021 | 1,259 | 102 | 4% (46) | 23% | $195,339 |
| 2020 | 1,643 | 81 | 3% (52) | 25% | $213,645 |
| 2019 | 2,292 | 171 | 4% (93) | 22% | $220,559 |
| 2018 | 1,546 | 194 | 3% (39) | 17% | $114,325 |
| 2017 | 397 | 75 | None | None | $39,029 |
| 2016 | 225 | 44 | 0% (0) | None | $17,760 |
| 2015 | 177 | 30 | 0% (0) | None | $15,952 |
| 2014 | 40 | None | 0% (0) | 38% | $5,396 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 44 drugs
| Ozempic | 32 | $35,582 | $1,112 |
| Trulicity | 18 | $20,718 | $1,151 |
| Jardiance | 13 | $14,438 | $1,111 |
| Myrbetriq | 11 | $8,088 | $735 |
| Buprenorphine | 21 | $5,169 | $246 |
| Lidocaine | 18 | $2,881 | $160 |
| Gabapentin | 59 | $2,290 | $39 |
| Pregabalin | 17 | $2,269 | $133 |
| Buprenorphine-Naloxone | 19 | $2,250 | $118 |
| Atorvastatin | 105 | $1,917 | $18 |
| Ventolin Hfa | 16 | $987 | $62 |
| Levothyroxine | 69 | $970 | $14 |
| Hydrocodone-Acetaminophen | 47 | $904 | $19 |
| Estradiol | 15 | $881 | $59 |
| Losartan | 59 | $827 | $14 |
| Baclofen | 18 | $811 | $45 |
| Albuterol Sulfate Hfa | 25 | $757 | $30 |
| Rosuvastatin | 23 | $715 | $31 |
| Duloxetine | 23 | $610 | $27 |
| Metformin | 56 | $603 | $11 |
| Escitalopram | 16 | $495 | $31 |
| Fluticasone Propionate | 26 | $476 | $18 |
| Trazodone | 23 | $433 | $19 |
| Diclofenac | 13 | $426 | $33 |
| Hydroxyzine | 21 | $411 | $20 |
| Amlodipine Besylate | 53 | $394 | $7 |
| Famotidine | 31 | $339 | $11 |
| Sertraline | 22 | $330 | $15 |
| Omeprazole | 21 | $324 | $15 |
| Metoprolol | 15 | $323 | $22 |
| Mirtazapine | 26 | $277 | $11 |
| Lisinopril | 37 | $268 | $7 |
| Pantoprazole | 15 | $242 | $16 |
| Ibuprofen | 25 | $218 | $9 |
| Zolpidem | 16 | $210 | $13 |
| Furosemide | 31 | $193 | $6 |
| Metformin Hcl Er | 17 | $179 | $11 |
| Simvastatin | 17 | $157 | $9 |
| Alendronate | 13 | $153 | $12 |
| Nitrofurantoin Mono-Macro | 12 | $130 | $11 |
| Hydrochlorothiazide | 17 | $123 | $7 |
| Cyclobenzaprine | 26 | $118 | $5 |
| Metoprolol | 19 | $106 | $6 |
| Meloxicam | 11 | $37 | $3 |
2022: 19 drugs
| Gabapentin | 53 | $1,416 | $27 |
| Albuterol Sulfate Hfa | 23 | $1,010 | $44 |
| Ventolin Hfa | 12 | $987 | $82 |
| Atorvastatin | 77 | $887 | $12 |
| Baclofen | 19 | $812 | $43 |
| Levothyroxine | 25 | $381 | $15 |
| Cyclobenzaprine | 28 | $375 | $13 |
| Losartan | 22 | $303 | $14 |
| Omeprazole | 26 | $236 | $9 |
| Venlafaxine Hcl Er | 13 | $236 | $18 |
| Amlodipine Besylate | 25 | $227 | $9 |
| Metformin | 29 | $214 | $7 |
| Fluticasone Propionate | 19 | $188 | $10 |
| Simvastatin | 16 | $162 | $10 |
| Lisinopril | 20 | $130 | $6 |
| Ibuprofen | 11 | $85 | $8 |
| Furosemide | 12 | $78 | $7 |
| Hydrochlorothiazide | 18 | $78 | $4 |
| Mirtazapine | 13 | $68 | $5 |
2021: 32 drugs
| Jardiance | 24 | $26,738 | $1,114 |
| Lantus Solostar | 18 | $9,395 | $522 |
| Anoro Ellipta | 12 | $5,436 | $453 |
| Flovent Diskus | 11 | $2,301 | $209 |
| Ventolin Hfa | 27 | $1,710 | $63 |
| Albuterol Sulfate Hfa | 33 | $1,446 | $44 |
| Atorvastatin | 54 | $955 | $18 |
| Gabapentin | 58 | $823 | $14 |
| Pregabalin | 15 | $801 | $53 |
| Ultra-Fine Mini Pen Needle | 16 | $798 | $50 |
| Baclofen | 33 | $787 | $24 |
| Hydrocodone-Acetaminophen | 22 | $471 | $21 |
| Lidocaine-Prilocaine | 22 | $463 | $21 |
| Duloxetine | 22 | $458 | $21 |
| Omeprazole | 50 | $375 | $7 |
| Losartan | 36 | $341 | $9 |
| Metoprolol | 14 | $326 | $23 |
| Trazodone | 20 | $291 | $15 |
| Metformin | 59 | $286 | $5 |
| Fluticasone Propionate | 22 | $281 | $13 |
| Venlafaxine Hcl Er | 16 | $271 | $17 |
| Ibuprofen | 37 | $258 | $7 |
| Amlodipine Besylate | 28 | $233 | $8 |
| Famotidine | 22 | $230 | $10 |
| Cyclobenzaprine | 18 | $161 | $9 |
| Simvastatin | 13 | $160 | $12 |
| Lisinopril-Hydrochlorothiazide | 11 | $134 | $12 |
| Lisinopril | 26 | $131 | $5 |
| Furosemide | 14 | $122 | $9 |
| Meloxicam | 13 | $108 | $8 |
| Metformin Hcl Er | 16 | $104 | $6 |
| Hydrochlorothiazide | 16 | $87 | $5 |
2020: 46 drugs
| Jardiance | 47 | $42,448 | $903 |
| Victoza 3-Pak | 26 | $20,687 | $796 |
| Lantus Solostar | 23 | $9,267 | $403 |
| Novolog Flexpen | 12 | $7,972 | $664 |
| Eliquis | 15 | $7,438 | $496 |
| Anoro Ellipta | 11 | $4,769 | $434 |
| Breo Ellipta | 12 | $4,497 | $375 |
| Ventolin Hfa | 50 | $3,581 | $72 |
| Pregabalin | 32 | $1,922 | $60 |
| Baclofen | 77 | $1,748 | $23 |
| Gabapentin | 78 | $1,517 | $19 |
| Albuterol Sulfate Hfa | 35 | $1,465 | $42 |
| Atorvastatin | 80 | $1,157 | $14 |
| Ultra-Fine Mini Pen Needle | 19 | $739 | $39 |
| Phenytoin Sodium Extended | 11 | $506 | $46 |
| Lidocaine-Prilocaine | 15 | $488 | $33 |
| Duloxetine | 19 | $468 | $25 |
| Levothyroxine | 24 | $445 | $19 |
| Cyclobenzaprine | 20 | $438 | $22 |
| Metformin | 60 | $367 | $6 |
| Losartan | 31 | $351 | $11 |
| Hydrocodone-Acetaminophen | 28 | $334 | $12 |
| Venlafaxine Hcl Er | 13 | $276 | $21 |
| Ibuprofen | 32 | $247 | $8 |
| Rosuvastatin | 11 | $224 | $20 |
| Famotidine | 20 | $222 | $11 |
| Hydroxyzine | 14 | $210 | $15 |
| Metformin Hcl Er | 30 | $198 | $7 |
| Pantoprazole | 21 | $195 | $9 |
| Aripiprazole | 11 | $189 | $17 |
| Naproxen | 21 | $182 | $9 |
| Lisinopril | 44 | $182 | $4 |
| Omeprazole | 27 | $180 | $7 |
| Fluticasone Propionate | 11 | $155 | $14 |
| Simvastatin | 17 | $154 | $9 |
| Amlodipine Besylate | 32 | $154 | $5 |
| Furosemide | 34 | $152 | $4 |
| Montelukast | 16 | $132 | $8 |
| Meloxicam | 24 | $121 | $5 |
| Trazodone | 15 | $118 | $8 |
| Metoprolol | 25 | $103 | $4 |
| Hydrochlorothiazide | 14 | $98 | $7 |
| Atenolol | 13 | $90 | $7 |
| Alendronate | 28 | $83 | $3 |
| Hydroxyzine Pamoate | 14 | $78 | $6 |
| Carvedilol | 12 | $54 | $5 |
2019: 55 drugs
| Truvada | 13 | $37,770 | $2,905 |
| Victoza 3-Pak | 29 | $18,857 | $650 |
| Jardiance | 22 | $15,503 | $705 |
| Lantus Solostar | 33 | $9,619 | $291 |
| Belbuca | 24 | $8,593 | $358 |
| Lyrica | 18 | $8,522 | $473 |
| Novolog Flexpen | 19 | $6,831 | $360 |
| Symbicort | 13 | $6,548 | $504 |
| Humalog Kwikpen U-100 | 12 | $4,613 | $384 |
| Ventolin Hfa | 46 | $3,262 | $71 |
| Gabapentin | 125 | $2,109 | $17 |
| Atorvastatin | 123 | $1,818 | $15 |
| Duloxetine | 25 | $1,622 | $65 |
| Venlafaxine | 16 | $1,089 | $68 |
| Levothyroxine | 59 | $835 | $14 |
| Celecoxib | 15 | $788 | $53 |
| Lidocaine-Prilocaine | 43 | $768 | $18 |
| Albuterol Sulfate Hfa | 17 | $744 | $44 |
| Phenytoin Sodium Extended | 16 | $670 | $42 |
| Metformin | 123 | $669 | $5 |
| Hydrocodone-Acetaminophen | 49 | $656 | $13 |
| Baclofen | 56 | $653 | $12 |
| Lisinopril | 100 | $575 | $6 |
| Metoprolol | 17 | $453 | $27 |
| Ranitidine | 58 | $420 | $7 |
| Ultra-Fine Mini Pen Needle | 14 | $408 | $29 |
| Amlodipine Besylate | 61 | $363 | $6 |
| Naproxen | 35 | $353 | $10 |
| Hydroxyzine | 22 | $300 | $14 |
| Losartan | 34 | $269 | $8 |
| Omeprazole | 30 | $267 | $9 |
| Cyclobenzaprine | 31 | $252 | $8 |
| Amitriptyline | 11 | $207 | $19 |
| Furosemide | 39 | $207 | $5 |
| Trazodone | 20 | $188 | $9 |
| Mirtazapine | 16 | $182 | $11 |
| Pravastatin | 11 | $179 | $16 |
| Carvedilol | 28 | $179 | $6 |
| Clopidogrel | 23 | $175 | $8 |
| Losartan-Hydrochlorothiazide | 15 | $164 | $11 |
| Hydrochlorothiazide | 49 | $161 | $3 |
| Pantoprazole | 25 | $157 | $6 |
| Simvastatin | 20 | $156 | $8 |
| Quetiapine | 15 | $147 | $10 |
| Tramadol | 12 | $131 | $11 |
| Clonidine | 16 | $124 | $8 |
| Alendronate | 19 | $117 | $6 |
| Glipizide | 20 | $108 | $5 |
| Metoprolol | 34 | $105 | $3 |
| Benazepril | 23 | $105 | $5 |
| Metformin Hcl Er | 15 | $104 | $7 |
| Ibuprofen | 15 | $102 | $7 |
| Atenolol | 18 | $102 | $6 |
| Meloxicam | 18 | $78 | $4 |
| Divalproex | 13 | $68 | $5 |
2018: 40 drugs
| Januvia | 24 | $12,898 | $537 |
| Tradjenta | 13 | $10,259 | $789 |
| Lantus Solostar | 19 | $5,600 | $295 |
| Symbicort | 13 | $4,843 | $373 |
| Ventolin Hfa | 40 | $2,201 | $55 |
| Atorvastatin | 91 | $1,169 | $13 |
| Gabapentin | 76 | $1,159 | $15 |
| Levothyroxine | 40 | $666 | $17 |
| Omeprazole | 29 | $517 | $18 |
| Metformin | 96 | $459 | $5 |
| Lisinopril | 59 | $439 | $7 |
| Lidocaine-Prilocaine | 23 | $436 | $19 |
| Hydrocodone-Acetaminophen | 29 | $403 | $14 |
| Metoprolol | 15 | $346 | $23 |
| Polyethylene Glycol 3350 | 16 | $320 | $20 |
| Nifedipine Er | 11 | $306 | $28 |
| Glimepiride | 19 | $299 | $16 |
| Potassium Chloride | 11 | $293 | $27 |
| Cyclobenzaprine | 20 | $268 | $13 |
| Quetiapine | 19 | $246 | $13 |
| Mirtazapine | 19 | $229 | $12 |
| Naproxen | 19 | $182 | $10 |
| Ranitidine | 25 | $178 | $7 |
| Amlodipine Besylate | 38 | $167 | $4 |
| Ibuprofen | 26 | $157 | $6 |
| Hydrochlorothiazide | 27 | $151 | $6 |
| Fluticasone Propionate | 12 | $148 | $12 |
| Furosemide | 31 | $139 | $4 |
| Glipizide Er | 21 | $138 | $7 |
| Fluoxetine | 17 | $136 | $8 |
| Pantoprazole | 11 | $131 | $12 |
| Hydroxyzine | 11 | $129 | $12 |
| Simvastatin | 25 | $119 | $5 |
| Losartan | 20 | $118 | $6 |
| Hydralazine | 13 | $116 | $9 |
| Carvedilol | 17 | $86 | $5 |
| Glipizide | 17 | $53 | $3 |
| Metoprolol | 18 | $52 | $3 |
| Trazodone | 11 | $46 | $4 |
| Lisinopril-Hydrochlorothiazide | 12 | $45 | $4 |
2017: 8 drugs
| Atorvastatin | 33 | $701 | $21 |
| Gabapentin | 36 | $579 | $16 |
| Omeprazole | 17 | $126 | $7 |
| Lisinopril | 21 | $117 | $6 |
| Metformin | 16 | $101 | $6 |
| Hydrochlorothiazide | 12 | $78 | $6 |
| Amlodipine Besylate | 11 | $39 | $4 |
| Furosemide | 11 | $34 | $3 |
2016: 4 drugs
| Atorvastatin | 12 | $279 | $23 |
| Gabapentin | 12 | $275 | $23 |
| Fluticasone Propionate | 15 | $158 | $11 |
| Omeprazole | 11 | $66 | $6 |
2015: 2 drugs
| Proair Hfa | 16 | $830 | $52 |
| Atorvastatin | 11 | $241 | $22 |
Professional record
- NPI
- 1457762619
- Licence
- CA 20A14218
- Trained
- Lake Erie College of Osteopathic Medicine, Erie, 2014
- Group
- Sutter Valley Medical Foundation · Sutter Bay Medical Foundation
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 155 15th St, West Sacramento, CA, 95691
- NPI first listed
- 2014-05-09
- NPI last updated
- 2025-02-28
- NPI record certified
- 2025-02-28
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 401 Paradise Rd Ste E, Modesto, CA, 95351